BioNTech SE, the University of Pennsylvania (Penn), and Osage University Partners (OUP) have announced the launch of the $50 million Penn-BioNTech Innovative Therapeutics Seed Fund (PxB Fund). This dedicated venture capital fund will support early-stage life science startups originating from Penn, aiming to accelerate the translation of biomedical research into new therapies and products. The initiative builds on BioNTech's longstanding collaboration with Penn and will leverage the combined expertise of all partners to foster innovation and bring transformative medical solutions to patients worldwide.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNTech SE published the original content used to generate this news brief via Business Wire (Ref. ID: 20260109684963) on January 09, 2026, and is solely responsible for the information contained therein.